Asymmetrex Continues Efforts to Raise Awareness of the Importance of Tissue Stem Cell Counting for Advancing Gene-Editing Therapeutics

At a conference on May 4-5, Boston stem cell medicine technology start-up Asymmetrex will target gene-editing scientists directly for relating the importance of incorporating the company’s stem cell counting technology into their work to develop new genetic therapies. The company will also discuss its technologies for expanding natural adult tissue stem cells, which are a rate-limiting factor for successful gene-editing therapeutics.

(PRWeb April 28, 2016)

Read the full story at http://www.prweb.com/releases/2016/04/prweb13377139.htm

For more information, please visit
http://www.prweb.com/releases/2016/04/prweb13377139.htm

You need to login to post comments.

Feed last updated 2024/03/31 @7:03 AM

0 COMMENTS:

VOCAPIA and SYSTRAN demonstrate an automated speech translation solution at EUROSATORY 2016 - GlobeNewswire (press release) views: 1533

Instagram is adding automatic in-app text translation - The Verge views: 1523

Here’s a ‘Brand-New’ Massive Multilingual Dataset for Machine Translation views: 1514

F.A.Q. | Terms and conditions